AAAisha Hussein Al‐Jamaei

Aisha Hussein Al‐Jamaei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aisha Hussein Al‐Jamaei has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Marco N. Helder

    Department of Oral and Maxillofacial Surgery/Oral Pathology, Amsterdam University Medical Centers and Academic Centre for Dentistry Amsterdam (ACTA), Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, 1081 HV Amsterdam, The Netherlands

    2 shared publications
  • A.A.H. Al-Jamaei

    Department of Oral and Maxillofacial Surgery and Oral Pathology, Amsterdam UMC-location VUMC/Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands

    1 shared publication
  • B.A.C. van Dijk

    Netherlands Comprehensive Cancer Organization (IKNL), Department of Research and Development, Utrecht, The Netherlands; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

    1 shared publication
  • Behrouz Zandieh Doulabi

    Department of Oral Cell Biology Academic Centre for Dentistry Amsterdam‐University of Amsterdam and VU Amsterdam Amsterdam The Netherlands

    1 shared publication
  • C. Rene Leemans

    Amsterdam UMC, Vrije Universiteit Amsterdam, Otolaryngology/Head and Neck Surgery, Cancer Center Amsterdam, The Netherlands

    1 shared publication
  • Eman Abdullah S. Al-Salami

    Histopathology and Tumors Department, Al-Mamoon Diagnostic Medical Center, Sana'a, Yemen

    1 shared publication

Latest Publications

  • Open Access

    Case Report: Multifocal Epithelial Hyperplasia in Two Yemeni Patients With Khat Chewing Habits

    by Layla Hafed, Munia Mahmood Shamsheer, Islam Alobaidy, Eman Abdullah S. Al-Salami, Fathia Gazem S. Awadhi, Hind Arhab, Aisha A. H. Al-Jamaei

    Multifocal epithelial hyperplasia (MEH) represents a benign condition associated with human papillomavirus. This condition is notably uncommon and primarily affects specific demographic groups, particularly children and adolescents. Within Yemen, similar to other Asian regions, the condition remains relatively uncommon. The lesions typically manifest intraorally on the labial and buccal mucosa as well as the tongue. In this report, we present two cases, where MEH was observed on the vermillion surface of the lips in adult patients. Several possible risk factors were identified in these cases, including socioeconomic disadvantage, khat chewing, and liver dysfunction. These findings emphasize the importance of considering MEH in the differential diagnosis of papillary lesions affecting the vermillion surfaces of the lips.

  • Open Access

    WEE1 kinase inhibitor MK‐1775 sensitizes oral tongue squamous cell carcinoma cells to radiation irrespective of TP53 status

    by Aisha Hussein Al‐Jamaei, Jan G. A. M. de Visscher, V. Ramadugula Subramanyam, Tymour Forouzanfar, Peter Sminia, Behrouz Zandieh Doulabi, Marco N. Helder

    Objective: Oral tongue squamous cell carcinoma (OTSCC) frequently harbors non‐functional p53 and depends on G2/M checkpoint mediated by WEE1. WEE1 suppression has been identified as a promising anti‐tumor strategy. This study investigated the capacity of WEE1 kinase inhibitor (MK‐1775) and its underlying mechanisms in enhancing radiation responses of OTSCC cells in vitro.Materials and methods: WEE1 kinase expression and its downstream target (CDK1) were investigated in OTSCC versus normal oral tissue. A synergistic combination of MK‐1775 with radiation on OTSCC cell lines with different p53 statuses was assessed by viability assay. The radio‐sensitizing effects of MK‐1775 on apoptosis, cell cycle, DNA damage, and mitotic entry were also determined.Results: Irradiation enhanced CDK1 expression in all tested cell lines, though the effect was far more pronounced in p53 mutated cell lines. MK‐1775 exhibited inhibitory effects against the survival of all cell lines and enhanced their response to the radiation. These effects were strongly elicited by induction of apoptosis and lethal mitosis, but less likely by abrogation of radiation‐induced G2 arrest.Conclusion: These results demonstrate the efficacy of MK‐1775 in enhancing the radiation effect on OTSCC in vitro associated with a significant apoptotic death rate, identifying WEE1 inhibitor as a potent radiosensitizer in OTSCC irrespective of p53 mutational status.